Normalized glandular dose coefficients for digital breast tomosynthesis systems with a homogeneous breast model

This work aims at calculating and releasing tabulated values of dose conversion coefficients, DgNDBT, for mean glandular dose (MGD) estimates in digital breast tomosynthesis (DBT). The DgNDBT coefficients are proposed in order to have an unique conversion coefficient for MGD estimates, in place of dose conversion coefficients in mammography (DgNDMorc,g,striad as proposed in worldwide quality assurance protocols) used together with the T correction factor. DgNDBTis the MGD per unit incident air kerma measured at the breast surface for a 0° projection and the entire tube load used for the scan. The dataset of polyenergetic DgNDBTcoefficients was derived via a Monte Carlo software based on Geant4 toolkit. Dose coefficients were calculated for a grid of values of breast characteristics (breast thickness in the range 20-90 mm and glandular fraction by mass of 1%, 25%, 50%, 75%, 100%) and the simulated geometries, scan protocols, irradiation geometries and typical spectral qualities replicated those of six commercial DBT systems (GE SenoClaire, Hologic Selenia Dimensions, GE Senographe Pristina, Fujifilm Amulet Innovality, Siemens Mammomat Inspiration and IMS Giotto Class). For given breast characteristics, target/filter combination, tube voltage and half value layer (HVL), two spectra with two HVL values have been simulated in order to permit MGD estimates from experimental HVL values via mathematical interpolation from tabulated values. The adopted breast model assumes homogenous composition of glandular and adipose tissues; it includes a 1.45-mm thick skin envelope in place of the 4-5 mm envelope commonly adopted in dosimetry protocols. The simulation code was validated vs. AAPM Task group 195 Monte Carlo reference data sets (absolute differences not higher than 1.1%) and by comparison to relative dosimetry measurements with radiochromic film in a PMMA test object (differences within the maximum experimental uncertainty of 11%). The calculated coefficients show maximum relative deviations of -17.6% and + 6.1% from those provided by the DBT dose coefficients adopted in the EUREF protocol and of 1.5%, on average, from data in the AAPM TG223 report. A spreadsheet is provided for interpolating the tabulated DgNDBTcoefficients for arbitrary values of HVL, compressed breast thickness and glandular fraction, in the corresponding investigated ranges, for each DBT unit modelled in this work.